IP Library Patent Application 14731108
Patent Application
App. No. 14/731,108

BLUE-GREEN ALGAE EXTRACT MIXTURES AND METHODS OF USE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/731,108
Abstract

Disclosed herein are compositions including a mixture of an aqueous extract of Aphanizomenon flos aquae and an aqueous extract of Arthrospira . The compositions are of use for inducing stem cell trafficking (such as stem cell mobilization and homing) in a subject. Thus, methods for increasing stem cell trafficking that include administering a effective amount of the mixture of the aqueous extract of Aphanizomenon fibs aquae and the aqueous extract of Arthrospira , are disclosed herein.

Claims (34)

1 . A composition, comprising a first component and a second component, wherein:

the first component comprises an aqueous extract of Arthrospira ; and

the second component comprises an aqueous extract of Aphanizomenon flos aquae.

2 . The composition of claim 1 , wherein

(a) the aqueous extract of Arthrospira comprises an aqueous extract of fresh, dehydrated, or preserved Arthrospira;

(b) the aqueous extract of Aphanizomenon flos aquae comprises an aqueous extract of fresh, dehydrated, or preserved Aphanizomenon flos aquae ; or

(c) both (a) and (b).

3 . The composition of claim 1 , wherein

(a) the first component consists of a dried form of the aqueous extract Arthrospira ; and

(b) the second component consists of a dried form of the aqueous extract of fresh, dehydrated, or preserved Aphanizomenon flos aquae ; or

(c) both (a) and (b).

4 . The composition of claim 1 , wherein the first component and the second component are mixed at a ratio of about 10:90 w/w to about 90:10 w/w.

5 . The composition of claim 1 , wherein the first component and the second component are mixed at a ratio selected from the group consisting of about 5:95 w/w, about 10:90 w/w, about 20:80 w/w, about 30:70 w/w, about 40:60 w/w, about 50:50 w/w, about 60:40 w/w, about 70:30 w/w, about 80:20 w/w, about 90:10 w/w, and about 95:5 w/w.

6 . The composition of claim 1 , wherein the Arthrospira comprises Arthrospira platensis, Arthrospira maxima , or both.

7 . The composition of claim 1 , wherein the aqueous extract is a water extract or a buffered saline extract.

8 . The composition of claim 1 , comprising about 0.5 grams to about 5 grams of the mixture of the first and second components.

9 . The composition of claim 8 , where in the composition comprises about 0.5 grams of the first component and about 0.5 grams of the second component.

10 . The composition of claim 1 , wherein the composition is a solid.

11 . The composition of claim 10 , wherein the solid is encapsulated.

12 . A liquid composition, comprising the composition of claim 1 dissolved in water.

13 . A composition comprising a therapeutically effective amount of the composition of claim 1 in a pharmacologically acceptable carrier.

14 . A method of increasing stem cell trafficking in a subject, comprising:

administering to the subject a therapeutically effective amount of the composition of claim 1 , thereby increasing stem cell trafficking in the subject.

15 . The method of claim 14 , wherein the subject is a mammal.

16 . The method of claim 15 , wherein the subject is a human.

17 . The method of claim 14 , wherein increasing stem cell trafficking comprises an increase in the number of circulating stem cells in the subject.

18 . The method of claim 14 , wherein the stem cell is an endothelial stem cell.

19 . The method of claim 18 , wherein the stem cell is a CD45−CD31+KDR+ stem cell.

20 . The method of claim 19 , further comprising measuring CD45−CD31+KDR+ stem cells in the subject.

21 . The method of claim 14 , wherein the stem cell is a hematopoietic stem cell.

22 . The method of claim 21 , wherein the stem cell is a CD34+ stem cell.

23 . The method of claim 22 , further comprising measuring CD34+ stem cells in the subject.

24 . The method of claim 14 , wherein increasing stem cell trafficking comprises an increase in stem cell mobilization and/or homing of about 50% to about 500% in the subject as compared to a control.

25 . The method of claim 14 , wherein the subject is a healthy subject, or is a subject with a chronic illness, traumatic injury, osteoporosis, Alzheimer's disease, cardiac infarction, Parkinson's disease, traumatic brain injury, multiple sclerosis, cirrhosis of the liver, a digestive system disorder, a nervous system disorder, a lymph system disorder, cardiovascular system disorder, an endocrine system disorder, a degenerative disease, or is immunosuppressed.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2015
From: JENSEN, GITTE S.; GUTHRIE, JESSE
To: DESERT LAKE TECHNOLOGIES, LLC
Reel/Frame 035790/0591 →
CHANGE OF NAME Recorded Jun 4, 2015
From: DESERT LAKE TECHNOLOGIES, LLC
To: CERULE, LLC
Reel/Frame 035830/0941 →